Title |
Perphenazine for schizophrenia
|
---|---|
Published in |
Cochrane database of systematic reviews, January 2005
|
DOI | 10.1002/14651858.cd003443.pub2 |
Pubmed ID | |
Authors |
Hartung B, Wada M, Laux G, Leucht S, Hartung, Benno, Wada, Makoto, Laux, Gerd, Leucht, Stefan |
Abstract |
Perphenazine is an old phenothiazine antipsychotic with a potency similar to haloperidol. It has been used for many years and is popular in the northern European countries and Japan. |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 2 | 5% |
Canada | 1 | 2% |
Unknown | 39 | 93% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 8 | 19% |
Student > Ph. D. Student | 5 | 12% |
Researcher | 5 | 12% |
Student > Doctoral Student | 4 | 10% |
Student > Postgraduate | 4 | 10% |
Other | 9 | 21% |
Unknown | 7 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 40% |
Psychology | 5 | 12% |
Agricultural and Biological Sciences | 3 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Neuroscience | 2 | 5% |
Other | 6 | 14% |
Unknown | 7 | 17% |